Transfusion News brings you the latest news in blood banking, transfusion medicine, tissue transplantation, blood policies, hematopoietic stem cells, cellular therapies and related fields. With concise news updates each week and the “Question of the Day” every Monday, Wednesday and Friday, Transfusion News is a valuable resource for professionals who want to stay up to date with all of the latest news in their field.
Garrett S. Booth, MD, MS is an Assistant Professor at Vanderbilt University Medical Center and Associate Medical Director of the Blood Bank at Vanderbilt University. He serves on a national committee for hemovigilance through the Centers for Disease Control and Prevention (CDC). He is co-editor of Transfusion Medicine Questions. His research interests include transfusion medicine education and personalized blood management safety.
Eric A. Gehrie, MD is Assistant Professor of Pathology at Johns Hopkins University and Associate Director of the blood bank at The Johns Hopkins Hospital. Dr. Gehrie’s research interests center around the detection and prevention of adverse events associated with blood transfusion and apheresis procedures.
Ronald Jackups, MD, PhD is an Assistant Professor of Pathology & Immunology and Pediatrics at Washington University School of Medicine in St. Louis. He serves as Medical Director of the blood bank and hematology laboratories at St. Louis Children’s Hospital and as Assistant Medical Director at Barnes-Jewish Hospital. He is co-founder and co-editor of Transfusion Medicine Questions. His research interests are in blood product and laboratory test utilization, inventory management, and transfusion education.
William Lane, MD, PhD is an Instructor in Pathology at Harvard Medical School and Director of Clinical Laboratory Informatics and Assistant Director of the Tissue Typing Laboratory at the Brigham and Women’s Hospital (BWH), Boston, MA. He is board certified in Clinical Pathology, Blood Banking/Transfusion Medicine, and Clinical Informatics. He is co-founder and co-editor of Transfusion Medicine Questions. He is founder of PathQuestions.com. His research interests include RBC and platelet antigen prediction.
Lorraine N. Blagg, MA, MLS(ASCP)CM SBB is the Education and Development Coordinator at The Johns Hopkins Hospital in Transfusion Medicine, a role which includes being the Program Director for The Johns Hopkins Hospital Specialist in Blood Banking Technology Program. She is also the co-chair of the Continuing Education Committee, P.A.C.E.® and CEBroker® Administrator for Johns Hopkins Medicine Department of Pathology and serves on other committees related to Allied Health Education and Competency Assessment.
Diarmaid Ó Donghaile, MB BCh, MD, FRCPath is the director of the Irish Unrelated Bone Marrow Donor Registry (IUBMR) and the National Tissue Typing Laboratory at the Irish Blood Transfusion Service. He is also a consultant haematologist at St. James’s Hospital Dublin, and lectures in transfusion medicine at Trinity College Dublin. He serves on the European Directorate for the Quality of Medicines & Healthcare (Council of Europe) Working Group on the Guide to the Preparation, Use and QA of Blood Components. His research interests include the clinical use of blood components and transfusion safety.
Donald “Joe” Chaffin, MD is the Chief Medical Officer for LifeStream, a Blood Systems-affiliated center in Southern California. Teaching is his passion and professional mission, and many know him best by his internet persona, “The Blood Bank Guy.” Since 1998, BBGuy.org has been dedicated to being a “go-to” resource for essential transfusion medicine education. He is also the host of the award-winning “Blood Bank Guy Essentials Podcast,” a biweekly interview series heard by over 10,000 monthly listeners around the world. Dr. Chaffin is a graduate of the Loma Linda University School of Medicine. He completed his residency in Anatomic and Clinical Pathology at Walter Reed Army Medical Center in Washington, DC, and served on active duty in the United States Army for nine years.
Transfusion News Sponsor
Who we are.
For five decades, Bio-Rad Laboratories has provided high quality diagnostic and life sciences products that help make patients’ lives better. Bio-Rad offers a broad range of innovative immunohematology and diagnostic testing solutions. Our product portfolio contains traditional testing methods and reagents as well as user-friendly and reliable automated instruments and their proprietary reagents. Located in Hercules, Calif., Bio-Rad is a respected partner of blood banking and clinical diagnostic labs the world over.
Founded in 1952, Bio-Rad got into the clinical diagnostics market in 1967, and in the 1980s worked with researchers from the famed Pasteur Institute to develop the first HIV tests. In 2007, Bio-Rad began taking steps to become a world leader in blood grouping and diagnostic testing. First it acquired DiaMed, whose IDMicro Typing Gel Cards offered a sensitive and stable testing methodology that produced easy to read and interpret results. Three years later, Bio-Rad acquired Biotest and its automated blood bank system, the TANGO™ optimo, as well as its full line of proprietary reagents.
Where we are going.
Bio-Rad will continue to develop traditional blood bank reagents and proprietary solid phase and microplate hemagglutination reagents for use on our automated systems. The FDA recently cleared our newly designed solid-phase automated system, the TANGO infinity®, which performs blood grouping and diagnostic testing with high security and simple, intuitive control. Currently pending FDA clearance is an automated gel instrument and proprietary gel reagents for the U.S. blood banking market. All traditional, solid phase and gel instruments, and reagents, as well as our remote monitoring and online diagnostic software systems, will then become one family.
AABB and Transfusion
Established in 1947, AABB is an international association of blood banks, including hospital and community blood centers, transfusion and transplantation services and individuals involved in activities related to transfusion and transplantation medicine. AABB supports high standards of medical, technical and administrative performance, scientific investigation, clinical application and education. It is dedicated to encouraging the voluntary donation of blood and other tissues and organs through education, public information and research. AABB member facilities are responsible for collecting virtually all of the nation’s blood supply and transfusing more than 80 percent. More than 2,200 institutions (community and hospital blood banks, hospital transfusion services and laboratories) and 8,500 individuals are members of AABB, including physicians, scientists, administrators, medical technologists, blood donor recruiters and public relations personnel. Members are located in all 50 states and 80 foreign countries. AABB’s active membership provides direction to the Association through its elected Board of Directors, and more than 30 committees of volunteer professionals.
TRANSFUSION is AABB’s scholarly, peer-reviewed monthly journal, publishing on the latest technological advances, clinical research, and controversial issues related to transfusion medicine, cellular and gene therapies, and tissue transplantation. Each issue addresses topics such as clinical transfusion, immunology, genetics, cellular therapy, and hematology.
The views expressed on this website do not necessarily reflect the views of AABB, Johns Hopkins University, Johns Hopkins Health System, Bio-Rad Laboratories, or Wiley.